Mullen, Alan C.

Control of Effector CD8 + T Cell Function by the Transcription Factor Eomesodermin

Pearce, E. L., Mullen, A. C., Martins, G. A., Krawczyk, C. M., Hutchins, A. S., Zediak, V. P., Banica, M., DiCioccio, C. B., Gross, D. A., Mao, C.-A., et al. (2003) · Science

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 1,014

Structural Analysis of CTLA-4 Function In Vivo

Masteller, E. L., Chuang, E., Mullen, A. C., Reiner, S. L., & Thompson, C. B. (2000) · The Journal of Immunology

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 252

Spatial transcriptomics of healthy and fibrotic human liver at single-cell resolution

Watson, B. R., Paul, B., Rahman, R. U., Amir-Zilberstein, L., Segerstolpe, Å., Epstein, E. T., Murphy, S., Geistlinger, L., Lee, T., Shih, A., et al. (2025) · Nature Communications

Single-cell and spatial transcriptomicsLiver physiology and pathology

Cited by 123

Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice

Alsamman, S., Christenson, S. A., Yu, A., Ayad, N. M. E., Mooring, M. S., Segal, J. M., Hu, J. K.-H., Schaub, J. R., Ho, S. S., Rao, V., et al. (2020) · Science Translational Medicine

Liver physiology and pathologySphingolipid Metabolism and Signaling

Cited by 122

Induction of Cytotoxic T Lymphocyte Antigen 4 (Ctla-4) Restricts Clonal Expansion of Helper T Cells

Doyle, A. M., Mullen, A. C., Villarino, A. V., Hutchins, A. S., High, F. A., Lee, H. W., Thompson, C. B., & Reiner, S. L. (2001) · The Journal of Experimental Medicine

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 102

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Arghiani, N., Weilheimer, A., Toles, B. J., Chen, J. Y., et al. (2025) · Nature Communications

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 5

Screening the human druggable genome identifies ABHD17B as an anti-fibrotic target in hepatic stellate cells

Li, W., Sparks, R. P., Sun, C., Yang, Y., Pantano, L., Kirchner, R., Weilheimer, A., Toles, B. J., Chen, J. Y., Moran, S. P., et al. (2023) · Nature Communications

Liver physiology and pathologyLiver Disease Diagnosis and Treatment

Cited by 5